The 2023 data reveals Croatia's leading use of antihypertensive medicine at 27.3 units, followed by Slovakia (17.1) and Slovenia (15.0). Year-on-year variations indicate a notable rise in Croatia (8.33%) and Australia (4.67%), while Slovakia and Austria experienced declines of -2.89% and -2.0% respectively. Over the past five years, the compound annual growth rate (CAGR) should also be examined for a comprehensive trend analysis.
Future trends to watch include the impact of aging populations on antihypertensive drug use, potential advancements in hypertension treatment, and the influence of healthcare policies across different nations on medication accessibility and use.
Top countries in Antihypertensive Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Croatia | 27.3 | 2023 | +7.06% | +8.33% | View data |
| 2 | 2 Slovakia | 17.1 | 2023 | +1.18% | -2.89% | View data |
| 3 | 3 Slovenia | 15 | 2023 | 0% | +0.27% | View data |
| 4 | 4 Germany | 14.2 | 2023 | 0% | +1.02% | View data |
| 5 | 5 United Kingdom | 13.7 | 2023 | -0.72% | 0% | View data |
| 6 | 6 Australia | 10.3 | 2023 | +3% | +4.67% | View data |
| 7 | 7 France | 8.6 | 2023 | -1.15% | -1.76% | View data |
| 8 | 8 Greece | 6.6 | 2023 | +1.54% | +2.27% | View data |
| 9 | 9 Austria | 6.6 | 2023 | -2.94% | -2% | View data |
| 10 | 10 Luxembourg | 5.4 | 2023 | +5.88% | +0.37% | View data |
